FOXO1 opposition of CD8+ T cell effector programming confers early memory properties and phenotypic diversity

Proceedings of the National Academy of Sciences of the United States of America

Volumn 114, Issue 42, 2017, Pages E8865-E8874

  Delpoux, Arnaud ^a,b   Lai, Chen Yen ^a,b   Hedrick, Stephen M ^a,b   Doedens, Andrew L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD8+ T cell; Host; Immune memory; Immunology; Pathogen

Indexed keywords

CD8 ANTIGEN; GZMB PROTEIN; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; INTERLEUKIN 7 RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN BCL 2; TBET PROTEIN; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; FOXO1 PROTEIN, MOUSE; GRANZYME; GZMB PROTEIN, MOUSE; HAVCR2 PROTEIN, MOUSE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HNF1A PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; KLRG1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CD8+ T LYMPHOCYTE; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTROLLED STUDY; EFFECTOR CELL; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MEMORY T LYMPHOCYTE; MOUSE; MTOR SIGNALING; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPIC VARIATION; PRIORITY JOURNAL; ANIMAL; ARENAVIRUS INFECTION; C57BL MOUSE; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHENOTYPE; PHYSIOLOGY; TRANSGENIC MOUSE; VIROLOGY;

ANIMALS; ARENAVIRIDAE INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FORKHEAD BOX PROTEIN O1; GRANZYMES; HEPATITIS A VIRUS CELLULAR RECEPTOR 2; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; IMMUNOLOGIC MEMORY; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; RECEPTORS, IMMUNOLOGIC;

EID: 85031327454     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1618916114     Document Type: Article

References (53)

1. Wherry EJ, Ahmed R (2004) Memory CD8 T-cell differentiation during viral infection. J Virol 78:5535–5545.
2. Chang JT, Wherry EJ, Goldrath AW (2014) Molecular regulation of effector and memory T cell differentiation. Nat Immunol 15:1104–1115.
3. Kaech SM, Cui W (2012) Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol 12:749–761.
4. Sarkar S, et al. (2008) Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J Exp Med 205:625–640.
5. Gerlach C, et al. (2010) One naive T cell, multiple fates in CD8+ T cell differentiation. J Exp Med 207:1235–1246.
6. Zhou X, et al. (2010) Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1. Immunity 33:229–240.
7. Jeannet G, et al. (2010) Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc Natl Acad Sci USA 107:9777–9782.
8. Hess Michelini R, Doedens AL, Goldrath AW, Hedrick SM (2013) Differentiation of CD8 memory T cells depends on Foxo1. J Exp Med 210:1189–1200.
9. Kim MV, Ouyang W, Liao W, Zhang MQ, Li MO (2013) The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection. Immunity 39: 286–297.
10. Tejera MM, Kim EH, Sullivan JA, Plisch EH, Suresh M (2013) FoxO1 controls effector-to-memory transition and maintenance of functional CD8 T cell memory. J Immunol 191: 187–199.
11. Rao RR, Li Q, Gubbels Bupp MR, Shrikant PA (2012) Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8+ T cell differentiation. Immunity 36:374–387.
12. Yui MA, Rothenberg EV (2014) Developmental gene networks: A triathlon on the course to T cell identity. Nat Rev Immunol 14:529–545.
13. Weber BN, et al. (2011) A critical role for TCF-1 in T-lineage specification and differentiation. Nature 476:63–68.
14. Willinger T, et al. (2006) Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo. J Immunol 176:1439–1446.
15. Pircher H, Bürki K, Lang R, Hengartner H, Zinkernagel RM (1989) Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 342: 559–561.
16. Best JA, et al.; Immunological Genome Project Consortium (2013) Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation. Nat Immunol 14:404–412.
17. He B, et al. (2016) CD8+ T cells utilize highly dynamic enhancer repertoires and regulatory circuitry in response to infections. Immunity 45:1341–1354.
18. Yang CY, et al. (2011) The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol 12:1221–1229.
19. Ji Y, et al. (2011) Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nat Immunol 12:1230–1237.
20. Joshi NS, et al. (2007) Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281–295.
21. Araki K, et al. (2009) mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108–112.
22. Pollizzi KN, et al. (2015) mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation. J Clin Invest 125:2090–2108.
23. Mayer C, Grummt I (2006) Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 25: 6384–6391.
24. Kaech SM, et al. (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 4: 1191–1198.
25. Sullivan BM, Juedes A, Szabo SJ, von Herrath M, Glimcher LH (2003) Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci USA 100: 15818–15823.
26. Joshi NS, et al. (2011) Increased numbers of preexisting memory CD8 T cells and decreased T-bet expression can restrain terminal differentiation of secondary effector and memory CD8 T cells. J Immunol 187:4068–4076.
27. Kalia V, et al. (2010) Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32:91–103.
28. McFarland HI, Nahill SR, Maciaszek JW, Welsh RM (1992) CD11b (Mac-1): A marker for CD8+ cytotoxic T cell activation and memory in virus infection. J Immunol 149: 1326–1333.
29. Tiemessen MM, et al. (2012) The nuclear effector of Wnt-signaling, Tcf1, functions as a T-cell-specific tumor suppressor for development of lymphomas. PLoS Biol 10: e1001430.
30. Germar K, et al. (2011) T-cell factor 1 is a gatekeeper for T-cell specification in response to Notch signaling. Proc Natl Acad Sci USA 108:20060–20065.
31. Heng TS, Painter MW; Immunological Genome Project Consortium (2008) The Immunological Genome Project: Networks of gene expression in immune cells. Nat Immunol 9:1091–1094.
32. Olson JA, McDonald-Hyman C, Jameson SC, Hamilton SE (2013) Effector-like CD8+ T cells in the memory population mediate potent protective immunity. Immunity 38: 1250–1260.
33. Couzin-Frankel J (2013) Breakthrough of the year 2013. Cancer immunotherapy. Science 342:1432–1433.
34. Kerdiles YM, et al. (2009) Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10:176–184.
35. Hand TW, Morre M, Kaech SM (2007) Expression of IL-7 receptor alpha is necessary but not sufficient for the formation of memory CD8 T cells during viral infection. Proc Natl Acad Sci USA 104:11730–11735.
36. Prlic M, Bevan MJ (2011) Cutting edge: β-Catenin is dispensable for T cell effector differentiation, memory formation, and recall responses. J Immunol 187:1542–1546.
37. Zhao DM, et al. (2010) Constitutive activation of Wnt signaling favors generation of memory CD8 T cells. J Immunol 184:1191–1199.
38. Yang Q, et al. (2013) T cell factor 1 is required for group 2 innate lymphoid cell generation. Immunity 38:694–704.
39. Banerjee A, et al. (2010) Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J Immunol 185:4988–4992.
40. Badovinac VP, Haring JS, Harty JT (2007) Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8+ T cell response to infection. Immunity 26:827–841.
41. Ueno H, Nakajo N, Watanabe M, Isoda M, Sagata N (2008) FoxM1-driven cell division is required for neuronal differentiation in early Xenopus embryos. Development 135: 2023–2030.
42. Wirth TC, et al. (2010) Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8+ T cell differentiation. Immunity 33:128–140.
43. Katayama K, Nakamura A, Sugimoto Y, Tsuruo T, Fujita N (2008) FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression. Oncogene 27:1677–1686.
44. Schmidt M, et al. (2002) Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22:7842–7852.
45. Roychoudhuri R, et al. (2016) BACH2 regulates CD8+ T cell differentiation by controlling access of AP-1 factors to enhancers. Nat Immunol 17:851–860.
46. Roychoudhuri R, et al. (2013) BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature 498:506–510.
47. Oestreich KJ, Huang AC, Weinmann AS (2011) The lineage-defining factors T-bet and Bcl-6 collaborate to regulate Th1 gene expression patterns. J Exp Med 208:1001–1013.
48. Dominguez CX, et al. (2015) The transcription factors ZEB2 and T-bet cooperate to program cytotoxic T cell terminal differentiation in response to LCMV viral infection. J Exp Med 212:2041–2056.
49. Lin WH, et al. (2015) Asymmetric PI3K signaling driving developmental and regenerative cell fate bifurcation. Cell Rep 13:2203–2218.
50. Paik JH, et al. (2007) FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128:309–323.
51. Zhang DJ, et al. (2005) Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J Immunol 174:6725–6731.
52. Monticelli LA, et al. (2009) Transcriptional regulator Id2 controls survival of hepatic NKT cells. Proc Natl Acad Sci USA 106:19461–19466.
53. Xue HH, et al. (2002) Serine phosphorylation of Stat5 proteins in lymphocytes stimulated with IL-2. Int Immunol 14:1263–1271.